Recovery Tracking: Measure Function, Not Hope
Why pain ratings alone are a shaky way to judge injury recovery, and how pairing them with objective functional measures gives a clearer picture over time.
Many people gauge how an injury is healing by asking a simple question: does it feel better than it did last week? That question is a natural starting point, but pain, on its own, is a surprisingly unreliable way to track recovery. Pain perception shifts with sleep quality, stress, mood, distraction, and even what someone expects to happen next. None of that means pain reports are meaningless. It means pain alone is a noisy signal, and noisy signals are hard to interpret when the goal is figuring out whether a rehab process is actually moving forward.
This article is about the concept of tracking recovery with more than one type of measurement, and why that combination tends to produce a clearer, more interpretable picture than a single daily pain score. It is a discussion of measurement methodology, not a rehab program, a loading schedule, or a substitute for individualized guidance from a qualified clinician.
A more complete tracking approach usually separates pain from function. Pain at rest and pain during a consistent, standardized test movement are one category. A second, distinct category is functional capacity: what the injured tissue or joint can actually do, measured in concrete units. Range of motion, expressed in degrees, is one example. Load tolerance (how much resistance a movement can handle before symptoms appear) is another. For certain regions of the body, researchers have built and validated formal questionnaires that combine several of these functional domains into a single score, so that severity can be compared over time or between people using the same yardstick. The VISA-A questionnaire for Achilles tendinopathy is one widely used example, built around pain, function in daily living, and sporting activity, and validated for reliability in a cohort of people with confirmed Achilles tendon symptoms.[1] A related instrument, the Patient-Rated Tennis Elbow Evaluation (PRTEE), was developed and validated the same way for lateral elbow tendinopathy, combining a pain subscale with a function subscale and demonstrating good reliability and sensitivity to change in people with that condition.[2] These tools exist because clinicians and researchers needed something more structured than 'how does it feel,' and because a validated, repeatable instrument makes it possible to tell a genuine change in status apart from day-to-day noise.
The reason to separate pain from function is that they can move independently, and that divergence is informative. A drop in pain at rest without any corresponding change in range of motion or load tolerance suggests something is reducing the sensation of pain, whether that is reduced inflammation, central nervous system adaptation, altered activity levels, or expectation effects, without necessarily reflecting a change in the underlying tissue capacity. A rise in functional capacity that outpaces the historical or expected recovery curve for that type of injury is a different kind of signal. Tracking only one of the two dimensions makes it impossible to tell these situations apart.
In practice, a functional log usually captures a small, consistent set of data points rather than an exhaustive one: a same-time-of-day pain rating at rest, a pain rating during the same standardized test movement each session, a next-day pain response after any loading activity, and a functional measure such as range of motion or a load tolerance figure for the affected joint or tendon. The value of these measures comes almost entirely from consistency. A goniometer reading, a grip-strength figure, or a note on how much resistance a movement tolerated before symptoms appeared is only meaningful if the test conditions (time of day, warm-up state, measurement technique) stay the same from one session to the next. A number that bounces around because the test itself changed is not evidence of anything happening in the tissue; it is evidence that the measurement was inconsistent. This is a methodological point about data quality, not a specific rehabilitation protocol to follow.
A second methodological idea worth understanding is the single-variable principle borrowed from basic experimental design. If several things change at once, whether that is a new exercise program, a new supplement, altered sleep, or anything else, and the overall picture improves a few weeks later, there is no way to know which factor, or which combination, was responsible. This is not a criticism of any particular intervention; it is simply a limitation of how cause and effect can be inferred from an uncontrolled change. Holding as many variables as possible steady while only one changes at a time, over a defined observation window, is the standard logic behind single-subject or 'N-of-1' experimental designs, which have an established methodological literature in clinical research as a way to draw more confident conclusions about an individual's response when a large controlled trial is not feasible.[3] In one early clinical series, the majority of completed single-subject trials produced a definite clinical or statistical answer for the individual patient, supporting the underlying logic of changing one variable at a time and observing the result.[3] Applying that same logic informally to a personal tracking log does not require a research background, only the discipline to change fewer things at once and to record what changed alongside the measurements.
What does the evidence actually show about why this separation matters? The clearest human evidence relates to how much of a pain report can be shaped by expectation rather than by tissue status alone. In a controlled imaging study using an opioid analgesic, researchers found that telling participants they were receiving a strong pain-relieving treatment roughly doubled the measured analgesic benefit compared to a neutral framing, while telling a separate group the treatment had been stopped almost eliminated the drug's measurable effect, even though the same infusion was running the entire time.[4] That is Strong Human Evidence that expectation can substantially move a subjective pain report independent of any change in the underlying physiological input, which is precisely why relying on pain scores alone makes it hard to separate a genuine change in tissue status from a change in how pain is being perceived and reported. The evidence supporting validated questionnaires like VISA-A and PRTEE as reliable, reproducible measurement instruments is also Strong Human Evidence, established through formal psychometric validation studies in the specific populations they were designed for.[1][2] That is a different claim from evidence about any particular treatment's effectiveness; it is evidence about the measurement tools themselves being trustworthy ways to quantify change.
There are real limitations here. Validated outcome measures like VISA-A and PRTEE were developed and tested in specific populations, often athletes with a confirmed diagnosis of one particular tendinopathy, and their properties may not transfer perfectly to every injury type, every activity level, or every stage of recovery. A phone-based goniometer or a simple load test does not carry the same validation history as a peer-reviewed questionnaire, even though it can still be useful as a personal, internally consistent measure over time. Tracking data also does not, by itself, prove that any single factor caused an observed change; it only makes competing explanations easier to distinguish than a single daily pain rating would. The single-variable approach also has a practical cost: holding everything else steady for a few weeks at a time is slower than changing several things simultaneously, and normal week-to-week variation in pain and function can still make a single observation window hard to interpret cleanly, even with good measurement discipline. And no amount of self-tracking replaces a clinical exam, imaging, or a qualified professional's assessment of whether a recovery is progressing normally, plateauing for expected reasons, or showing signs that warrant a change in approach.
In practical terms, the value of separating pain from function, using a consistent test movement, and changing one variable at a time is that it turns a vague impression into something that can be reviewed over weeks rather than days, which tends to smooth out the noise that day-to-day pain ratings are prone to. This article describes tracking as an educational concept, not a program to follow, and it does not offer individualized dosing, loading, or progression instructions. Any decision about how quickly to progress a rehabilitation plan, how to interpret a personal tracking log, or how to respond to a plateau or setback should involve a qualified clinician or physical therapist who can assess the specific injury directly.
References & sources
- Robinson JM, Cook JL, Purdam C, et al. (2001). The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. British Journal of Sports Medicine.
- Rompe JD, Overend TJ, MacDermid JC (2007). Validation of the Patient-rated Tennis Elbow Evaluation Questionnaire. Journal of Hand Therapy.
- Guyatt GH, Keller JL, Jaeschke R, et al. (1990). The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Annals of Internal Medicine.
- Bingel U, Wanigasekera V, Wiech K, et al. (2011). The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Science Translational Medicine.
LearnPeptides is an independent education resource. We summarize public research and do not sell or recommend sources.
Related articles
View all articlesBPC-157 and TB-500: What the Evidence Actually Shows
What BPC-157 and TB-500 are, what animal and limited human data show about tissue repair, and where the evidence gaps are.
BPC-157: Preclinical promise meets clinical silence
Extensive animal research, zero completed human trials. Here's what the evidence actually shows and what remains unknown.
Gut healing claims: what the evidence actually supports
Peptides show promise in animal models. Zero human trials prove they fix digestive problems. Here's what that gap means.
Human Data vs Animal Data: A Reality Check for Recovery Peptides
Animal data on recovery peptides like BPC-157 is real, but human evidence is thin. Here is an honest look at what is actually proven versus assumed.

